Dr. Kalyanam Shivkumar Named New Editor of JACC: Clinical Electrophysiology

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

A specialist in interventional cardiac electrophysiology, Dr. Kalyanam Shivkumar has developed several innovative techniques for the catheter ablation of cardiac arrhythmias and other cardiac interventions. His research work, both basic/translational and clinical, relates to mechanisms of cardiac arrhythmias in humans and the role of the autonomic nervous system in sudden cardiac death. Shivkumar has been elected as a Fellow of the American College of Cardiology (FACC) and to the membership of the American Society of Clinical Investigation.

“It is a rare honor and a privilege to serve as the editor-in-chief of JACC: Clinical Electrophysiology,” Shivkumar said. “Our editorial team looks forward to seeking and publishing the very best science in the field of cardiac arrhythmias.”

Launched in 2015, JACC: Clinical Electrophysiology is a monthly subspecialty journal encompassing all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. The journal occupies a unique position by focusing primarily on the practicing clinical electrophysiologist’s need for context and critical information to direct therapeutic decision making. It aims to publish only the highest caliber papers and authors, focusing on content that advances the field.

Shivkumar’s first issue of JACC: Clinical Electrophysiology will publish in July 2020.

spot_img

DON'T MISS

Related Articles